Vanguard Capital Management 13D/13G Filings for Kura Oncology, Inc. (KURA)

Vanguard Capital Management 13D and 13G filings for Kura Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-04-30
11:01 am
Purchase
2026-03-3113GKURA ONCOLOGY INC
KURA
Vanguard Capital Management4,428,812
5.010%
4,428,812increase
(New Position)
Filing